Project description
Delivering personalised nanomedicine at the tumour microenvironment
There are many diseases with unmet medical needs including cancer. Nanotechnology has emerged as a promising solution for encapsulating drugs and increasing their stability and biodistribution. The EU-funded ICARUS project is interested to improve the efficacy and therapeutic outcome of custom-made anti-cancer nanomedicines. These nanomedicines are biodegradable and demonstrate a great pharmacokinetic profile. During ICARUS, researchers plan to develop innovative state-of-the-art analytical methodologies that will help elucidate the distribution and behaviour of these nanomedicines at the tumour microenvironment. Results will pave the way for better-tolerated drugs in comparison to conventional treatment modalities.
Fields of science
Programme(s)
Funding Scheme
CSA-LSP - Coordination and support action Lump sum
Coordinator
6229 EV Maastricht
Netherlands
See on map